J&J Unit Recalls Antipsychotic Syringes Over Cracks

Law360, New York (February 16, 2011, 6:42 PM EST) -- Johnson & Johnson unit Janssen has voluntarily recalled 70,000 syringes with the antipsychotic drug Invega Sustenna, saying some may contain cracks that pose a possible infection risk.

Titusville, N.J.-based Janssen, part of the pharmaceutical and medical device giant's Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary, published a letter dated Friday saying it had recalled 10 lots of 234-milligram doses of its Invega Sustenna, or paliperidone palmitate, extended-release injectable suspension.

Some of the prefilled syringes could contain a crack in the syringe barrel that would not be detectable by the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.